Anchiano Therapeutics
Biotechnology ResearchUnited States11-50 Employees
Anchiano Therapeutics is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer.
Insights
Focused Oncology Research Anchiano Therapeutics specializes in targeted cancer therapies, presenting opportunities to offer complementary research tools, clinical trial services, or therapeutic compounds aimed at oncology development pipelines.
Recent Collaborations The company's partnerships with ADT Pharmaceuticals and Chemomab suggest openness to collaborative research and licensing deals, providing potential avenues for joint ventures or licensing of innovative compounds.
Investments & Funding With a $23 million funding round and a focus on advancing small-molecule inhibitors, there are opportunities for investors or suppliers of biotech R&D solutions to engage through strategic partnerships or financings.
Pipeline Development Their ongoing development of inhibitors targeting RAS and PDE10/β-catenin offers a chance to provide specialized compounds, research reagents, or diagnostic tools supporting their experimental therapies.
Market Position & Growth As a growing biotech with recent mergers and strategic focus, engaging in consulting, market analysis, or service offerings tailored to emerging biotech firms could support their growth and accelerate product development.
Similar companies to Anchiano Therapeutics
Xoma
$1M$10MCompugen
$25M$50MAnaptysBio
$10M$25MChemoCentryx
$25M$50MFortress Biotech
$50M$100MAkebia Therapeutics
$100M$250M
Anchiano Therapeutics Tech Stack
Anchiano Therapeutics uses 8 technology products and services including Sucuri, jsDelivr, MySQL, and more. Explore Anchiano Therapeutics's tech stack below.
- SucuriContent Delivery Network
- jsDelivrContent Delivery Network
- MySQLDatabase
- Google Fonts APIFont Scripts
- jQuery MigrateJavascript Libraries
- Slider RevolutionMiscellaneous
- PHPProgramming Languages
- reCAPTCHASecurity
Media & News
Anchiano Therapeutics's Email Address Formats
Anchiano Therapeutics uses at least 1 format(s):
| Anchiano Therapeutics Email Formats | Percentage |
| First.Last@anchiano.com | 50% |
| First.Last@anchiano.com | 50% |
Frequently Asked Questions
Where is Anchiano Therapeutics's headquarters located?
Anchiano Therapeutics's main headquarters is located at One Kendall Square, BLDG 1400E, STE 14-105 Cambridge, MA 02139, US. The company has employees across 1 continents, including North America. What is Anchiano Therapeutics's stock symbol?
Anchiano Therapeutics is a publicly traded company; the company's stock symbol is CMMB. What is Anchiano Therapeutics's official website and social media links?
Anchiano Therapeutics's official website is anchiano.com and has social profiles on LinkedInCrunchbase.What is Anchiano Therapeutics's SIC code NAICS code?
Anchiano Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Anchiano Therapeutics have currently?
As of October 2025, Anchiano Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Executive Assistant To The Chief Executive Officer: K. L. A.Vp Of Research & Development: M. G.Vice President, Business Development: S. R.. Explore Anchiano Therapeutics's employee directory with LeadIQ.What industry does Anchiano Therapeutics belong to?
Anchiano Therapeutics operates in the Biotechnology Research industry. What technology does Anchiano Therapeutics use?
Anchiano Therapeutics's tech stack includes SucurijsDelivrMySQLGoogle Fonts APIjQuery MigrateSlider RevolutionPHPreCAPTCHA. What is Anchiano Therapeutics's email format?
Anchiano Therapeutics's email format typically follows the pattern of First.Last@anchiano.com. Find more Anchiano Therapeutics email formats with LeadIQ. How much funding has Anchiano Therapeutics raised to date?
As of October 2025, Anchiano Therapeutics has raised $23M in funding. The last funding round occurred on Apr 13, 2018 for $23M.When was Anchiano Therapeutics founded?
Anchiano Therapeutics was founded in 2004.
Company Overview
- Headquarters
- One Kendall Square, BLDG 1400E, STE 14-105 Cambridge, MA 02139, US
- Website
- anchiano.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- CMMB
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2004
- Employees
- 11-50
Media & News
Funding & Financials
- $23M
Anchiano Therapeutics has raised a total of $23M of funding over 3 rounds. Their latest funding round was raised on Apr 13, 2018 in the amount of $23M.
- $1M
Anchiano Therapeutics's revenue is estimated to be in the range of $1M
Funding & Financials
- $23M
Anchiano Therapeutics has raised a total of $23M of funding over 3 rounds. Their latest funding round was raised on Apr 13, 2018 in the amount of $23M.
- $1M
Anchiano Therapeutics's revenue is estimated to be in the range of $1M
Company Leadership
K. L. A.Executive Assistant To The Chief Executive Officer
M. G.Vp Of Research & Development- S. R.Vice President, Business Development
Employee Directory
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
